Literature DB >> 802124

Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases.

D Greenwood, N J Pearson, F O'Grady.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 802124     DOI: 10.1093/jac/2.4.337

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  The in vitro and in vivo Antibacterial Activity of Cefuroxime.

Authors:  S Goto
Journal:  Proc R Soc Med       Date:  1977

2.  Cefuroxime in the treatment of bacterial infections in seriously ill patients admitted to an intensive care unit.

Authors:  M Gobernado; J Gudin; M Santos; J Gregori; E Canton; C Ferrando
Journal:  Proc R Soc Med       Date:  1977

3.  Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.

Authors:  B Olsson; K Dornbusch; C E Nord
Journal:  Med Microbiol Immunol       Date:  1977-10-07       Impact factor: 3.402

4.  Fluorimetric determination of cefuroxime in body fluids.

Authors:  Z H Al-Rawi; S Tabaqchali
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

5.  Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.

Authors:  R P Mouton; G P Bongaerts; M van Gestel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

Review 6.  Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.

Authors:  R P Mouton
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

7.  Drug-Releasing Antibacterial Coating Made from Nano-Hydroxyapatite Using the Sonocoating Method.

Authors:  Khaled AbouAitah; Monika Bil; Elzbieta Pietrzykowska; Urszula Szałaj; Damian Fudala; Bartosz Woźniak; Justyna Nasiłowska; Anna Swiderska-Sroda; Maciej Lojkowski; Barbara Sokołowska; Wojciech Swieszkowski; Witold Lojkowski
Journal:  Nanomaterials (Basel)       Date:  2021-06-28       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.